Upgrade to SI Premium - Free Trial

JPMorgan Assumes Moderna (MRNA) at Neutral

August 1, 2022 5:03 PM
JPMorgan analyst Jessica Fye assumes coverage on Moderna (NASDAQ: MRNA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage

Next Articles